Reference : Overcoming problems with adherence to osteoporosis medication.
Scientific journals : Article
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/87417
Overcoming problems with adherence to osteoporosis medication.
English
Rabenda, Véronique mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
2010
Expert review of pharmacoeconomics & outcomes research
10
6
677-89
Yes
International
1473-7167
1744-8379
England
[en] adherence ; bisphosphonates ; compliance ; fracture ; osteoporosis ; persistence
[en] Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on patients and healthcare resources. Most importantly, low adherence rates consistently result in increased rates of fractures. However, it seems that efforts to evaluate and improve rates of both compliance and persistence are increasing. The extension of dosing intervals may be an element, among others, allowing improvements in therapeutic adherence. Improved patient education, enhancing healthcare provider-patients interaction, taking into account patient's preferences and involving them in treatment decisions may improve adherence.
http://hdl.handle.net/2268/87417
10.1586/erp.10.76

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Overcoming problems with adherence to osteoporosis medication.pdfPublisher postprint1.46 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.